Epoprostenol (FLOLAN) is an intravenous medication used to treat primary pulmonary hypertension (PPH), a condition characterized by progressive increases in pulmonary artery pressure, leading to right ...
Dallas, TX - As new agents are developed for the treatment of primary pulmonary hypertension (PPH), long-term data are now becoming available on the first drug approved for this indication, ...
A first-of-its-kind oral drug has been shown to successfully treat primary pulmonary hypertension (PPH), according to the results of a multi-center trial led by UCSD School of Medicine pulmonary ...
Myogen Receives Flolan Rights in U.S. and Will Launch Commercial Operations in Q2 '06 GlaxoSmithKline (LSE: GSK) (NYSE: GSK) and Myogen, Inc. (Nasdaq: MYOG) today announced a two-part collaboration in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results